The antinociceptive effects of anticonvulsants in a mouse visceral pain model

Anesthesia and Analgesia

Volumn 106, Issue 6, 2008, Pages 1897-1903

  Stepanovíc Petrovíc, Radica M ^a   Tomíc, Maja A ^a   Vučkovíc, Sonja M ^b   Paranos, Sonja ^a   Ugrešíc, Nenad D ^a   Prostran, Milica Š ^b   Milovanovíc, Slobodan ^c   Boškovíc, Bogdan ^c  

^a Faculty of Pharmacy   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; OXCARBAZEPINE; TOPIRAMATE; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG DERIVATIVE; FRUCTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG TOLERABILITY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; VISCERAL PAIN; WRITHING TEST; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; INNERVATION; MOTOR ACTIVITY; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; TIME; VISCERA;

ACETIC ACID; AMINES; ANALGESICS; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT; ROTAROD PERFORMANCE TEST; TIME FACTORS; VISCERA;

EID: 44649102665     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318172b993     Document Type: Article

References (38)

1. Giamberardino MA. Recent and forgotten aspects of visceral pain. Eur J Pain 1999;3:77-92
2. Emanuel EJ, Emanuel LL Palliative and end-of-life care. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison's principles of internal medicine. 16th ed. McGraw-Hill Medical Publishing Division, New York; 2005:53-66
3. Rorarius MG, Mennander S, Suominen P, Rintala S, Puura A, Pirhonen R, Salmelin R, Haanpaa M, Kujansuu E, Yli-Hankala A. Gabapentin for the prevention of postoperative pain after vaginal hysterectomy. Pain 2004;110:175-81
4. Reichert JA, Daughters RS, Rivard R, Simone DA. Peripheral and preemtive opioid antinociception in a mouse visceral pain model. Pain 2001;89:221-7
5. Satyanarayana PSV, Jain NK, Singh A, Kulkarni SK. Isobolographic analysis of interaction between cyclooxigenase inhibitors and tramadol in acetic acid-induced writhing in mice. Prog Neuro-Psychopharmacol 2004;28:641-9
6. Cervero F, Laird JMA. Visceral pain. Lancet 1999;353:2145-8
7. Ulugö l A, Ö zyigit F, Yesilyurt Ö, Dogrul A. The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac. Anesth Analg 2006;102:443-7
8. Rang HP, Dale MM, Ritter JM, Moore PK. Antiepileptic drugs. In: Pharmacology. 6th ed. International edition: Churchill Livingstone Elsevier; 2007:575-87
9. Chong MS, Libretto SE. The rationale and use of topiramate for treating neuropathic pain. Clin J Pain 2003;19:59-68
10. Chapman V, Suzuki R, Chamarette HL, Chapman V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998;75:261-72
11. Kiguchi S, Imamura T, Ichikawa K, Kojima M. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Clin Exp Pharmacol Physiol 2004;31:57-64
12. Jang Y, Kim ES, Park SS, Lee J, Moon DE. The suppressive effects of oxcarbazepine on mechanical and cold allodynia in a rat model of neuropathic pain. Anesth Analg 2005;101:800-6
13. Benoliel R, Tal M, Eliav E. Effects of topiramate on the chronic constriction injury model in the rat. J Pain 2006;7:878-83
14. Tomic' MA, Vučkovic' SM, Stepanovic'-Petrovic' RM, Ugrešic' N, Prostran MS, Boškovi'c B. The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 2004;111:253-60
15. Shannon HE, Eberle EL, Peters SC. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neuropharmacology 2005;48:1012-20
16. Vučkovic' SM, Tomic' MA, Stepanovic'-Petrovic' RM, Ugrešic' N, Prostran MS, Boškovi'c B. The effects of alpha(2)-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain 2006;125:10 -19
17. Urban MO, Ren K, Park KT, Campbell B, Anker N, Stearns B, Aiyar J, Belley M, Cohen C, Bristow L. Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action. J Pharmacol Exp Ther 2005;313:1209-16
18. Vučkovic' SM, Tomic' MA, Stepanovic'-Petrovic' RM, Ugrešic' N, Prostran MS, Boškovi'c B. Peripheral Antinociception by Carbamazepine in an Inflammatory Mechanical Hyperalgesia Model in the Rat: a New Target for Carbamazepine? J Pharmacol Sci 2006;100:310-14
19. Tomic' MA, Vučkovic' SM, Stepanovic'-Petrovic' RM, Ugrešic' N, Prostran MS, Boškovi'c B. Peripheral anti-hyperalgesia by oxcarbazepine: involvement of adenosine A1 receptors. Pharmazie 2006;61:566-8
20. 2- adrenoceptors in the anti-hyperalgesic effect of oxcarbazepine in a rat model of inflammatory pain. Anesth Analg 2007;105:1474-81
21. Carlton SM, Zhou S. Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin. Pain 1998;76:201-7
22. Feng Y, Cui M, Willis WD. Gabapentin markedly reduces acetic acid-induced visceral nociception. Anesthesiology 2003;98:729-33
23. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001;53:597-652
24. Dubinsky B, Gebre-Mariam S, Capetola RJ, Rosenthale ME. The analgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia. Agents Actions 1987;20:50-60
25. Tanaka K, Shimotori T, Makino S, Aikawa Y, Inaba T, Yoshida C, Takano S. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7- methylsulfonylamino-6-phenoxy- 4H-1-benzopyran-4-o ne. 1st communication: antiinflammatory, analgesic and other related properties. Arzneimittelforschung 1992;42:935-44
26. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs. 2nd ed. New York: Springer Verlag; 1986
27. Kinnard WR, Carr CJ. A preliminary procedure for evaluation of central nervous system depressants. J Pharmacol Exp Ther 1957;121:354-6
28. Vogel GH, Vogel WH, eds. Rotarod method. In: Drug discovery and evaluation, pharmacological assays. Berlin: Springer- Verlag; 1997:212-13
29. Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F. Carbamazepine exerts anti-inflammatory effects in the rat. Eur J Pharmacol 1995;294:71-4
30. Pechlivanova DM, Georgiev VP. Interaction of angiotensin II and adenosine A1 and A2A receptor ligands on the writhing test in mice. Pharmacol Biochem Behav 2002;72:23-8
31. 2- Adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolones, but not of dipyrone. Eur J Pharmacol 2004;496:93-7
32. Bischofs S, Zelenka M, Sommer C. Evaluation of topiramate as an anti-hyperalgesic and neuroprotective agent in the peripheral nervous system. J Peripheral Nerv Syst 2004;9:70-8
33. Angehagen M, Ben-Menachem E, Ronnback L, Hansson E. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabin and topiramate. Neurochem Res 2003;28:333-40
34. Wieczorkiewicz-Plaza A, Plaza P, Maciejewski R, Czuczwar M, Przesmycki K. Effect of topiramate on mechanical allodynia in neuropathic pain model in rats. Pol J Pharmacol 2004;56:275-8
35. Collier HO, Dinneen LC, Johson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in mouse. Br J Pharmacol 1968;32:295-310
36. Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro- 5H-dibenz(b,f)azepine-5- carboxamide derivatives. J Med Chem 1999;42:2582-7
37. Tutka P, Mroz T, Klucha K, Piekarczyk M, Wielosz M. Bupropion-induced convulsions:Preclinical evaluation of antiepileptic drugs. Epilepsy Res 2005;64:13-22
38. Luszczki JJ, Andres MM, Czuczwar P, Cioczek-Czuczwar A, Wojcik-Cwikla J, Ratnaraj N, Patsalos PN, Czuczwar SJ. Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice. Eur Neuropsychopharmacol 2005;15:609-16